Shawn He
Chief Scientific Officer JW Therapeutics
Shawn He, PhD, is Chief Scientific Officer at JW Therapeutics. Prior to joining JW, he served as CSO at Cure Genetics, where he built a CAR-NKT pipeline for solid tumors. Previously, he was EVP of R&D at Celularity, leading development of novel allogeneic CAR-T and CAR-NK therapies. Earlier, Dr. He held roles of increasing responsibility at Celgene Cellular Therapeutics, advancing three cell therapy programs into IND-enabling studies, all of which entered the clinic across eight indications. He received his PhD from the University of Maryland, College Park.
Seminars
Wednesday 15th July 2026
Ensuring Comparability Across Clinical Phases to Achieve Commercial Success with Relma-cel CAR-T Therapy
9:00 am
- Implementing phase-appropriate comparability strategies from phase one through phase three to maintain product consistency while transitioning from manual to automated processing
- Navigating critical process changes including automation of culture operations to balance regulatory expectations with commercial manufacturing scalability and cost effectiveness
- Establishing robust comparability frameworks early in development to prevent late-stage regulatory setbacks when integrating closed automated systems for commercial transition
